Teleflex Inc. (TBH)
XDUS 
Summary
TBH Chart
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business
WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. The acquisition adds a broad portfolio of therapeutic products to Teleflex's portfolio of interventional access products, driving an enhanced global presence in the cath lab. The Vascular Intervention business will also establish Teleflex's global footprint in the fast-growing peripheral intervention market, and provide a channel for Teleflex products that currently have a peripheral indication.
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
Timed with National Men's Health Month, the Prostate Monster ad campaign shines a light on quality-of-life issues associated with benign prostatic hyperplasia or BPH—a condition affecting millions of men 1 —and encourages them to take control of their health.
Teleflex Incorporated Announcement: If You Have Suffered Losses in Teleflex Incorporated (NYSE: TFX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public.
Teleflex Inc. Dividends
| TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 3 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 7 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 10 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 14 May 2024 Paid | Quarterly | $0.34 Per Share |
Teleflex Inc. Earnings
| 30 Jul 2025 (In 3 weeks) Date | | 3.36 Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
| TFX In 1 month Estimated | Quarterly | $0.34 Per Share |
| TFX 1 month ago Paid | Quarterly | $0.34 Per Share |
| TFX 3 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 7 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 10 months ago Paid | Quarterly | $0.34 Per Share |
| TFX 14 May 2024 Paid | Quarterly | $0.34 Per Share |
| 30 Jul 2025 (In 3 weeks) Date | | 3.36 Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 20 Feb 2025 Date | | 3.88 Cons. EPS | 3.89 EPS |
| 31 Oct 2024 Date | | 3.39 Cons. EPS | 3.49 EPS |
| 1 Aug 2024 Date | | 3.33 Cons. EPS | 3.42 EPS |
Teleflex Inc. (TBH) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has Teleflex Inc. ever had a stock split?
Teleflex Inc. Profile
| Medical - Instruments & Supplies Industry | Healthcare Sector | Liam J. Kelly CEO | XDUS Exchange | US8793691069 ISIN |
| US Country | 14,100 Employees | 20 May 2025 Last Dividend | 17 Jun 1997 Last Split | 18 Feb 1988 IPO Date |
Overview
Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.
Products and Services
- Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
- Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
- Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
- Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
- Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
- Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
- Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
- Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.
Contact Information
